PotlatchDeltic [PCH] vs Rayonier [RYN] Detailed Stock Comparison

PotlatchDeltic
NASDAQ
Loading...

Rayonier
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: PotlatchDeltic wins in 6 metrics, Rayonier wins in 14 metrics, with 0 ties. Rayonier appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | PotlatchDeltic | Rayonier | Better |
---|---|---|---|
P/E Ratio (TTM) | 80.19 | 10.85 | Rayonier |
Price-to-Book Ratio | 1.71 | 1.81 | PotlatchDeltic |
Debt-to-Equity Ratio | 54.97 | 45.01 | Rayonier |
PEG Ratio | -1.70 | 0.00 | PotlatchDeltic |
EV/EBITDA | 25.69 | 8.27 | Rayonier |
Profit Margin (TTM) | 3.94% | 61.39% | Rayonier |
Operating Margin (TTM) | 4.91% | 13.78% | Rayonier |
EBITDA Margin (TTM) | 4.91% | 13.78% | Rayonier |
Return on Equity | 2.07% | 18.02% | Rayonier |
Return on Assets (TTM) | 1.17% | 7.07% | Rayonier |
Free Cash Flow (TTM) | $67.47M | $159.06M | Rayonier |
Dividend Yield | 5.35% | 3.67% | PotlatchDeltic |
1-Year Return | -3.17% | -15.36% | PotlatchDeltic |
Price-to-Sales Ratio (TTM) | 3.11 | 3.39 | PotlatchDeltic |
Enterprise Value | $4.24B | $4.36B | Rayonier |
EV/Revenue Ratio | 4.02 | 3.52 | Rayonier |
Gross Profit Margin (TTM) | 12.97% | 29.69% | Rayonier |
Revenue per Share (TTM) | $13 | $8 | PotlatchDeltic |
Earnings per Share (Diluted) | $0.53 | $2.48 | Rayonier |
Beta (Stock Volatility) | 1.11 | 1.02 | Rayonier |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
PotlatchDeltic vs Rayonier Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
PotlatchDeltic | 0.57% | 5.67% | 4.27% | 6.39% | -0.16% | 8.62% |
Rayonier | -1.19% | 1.70% | 4.51% | 16.45% | -0.04% | 3.26% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
PotlatchDeltic | -3.17% | -0.12% | -8.90% | 41.25% | 21.11% | 4.38% |
Rayonier | -15.36% | -14.55% | -5.81% | 17.06% | 10.84% | 50.03% |
Performance & Financial Health Analysis: PotlatchDeltic vs Rayonier
Metric | PCH | RYN |
---|---|---|
Market Information | ||
Market Cap | $3.34B | $4.19B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 634,590 | 921,870 |
90 Day Avg. Volume | 563,533 | 1,040,337 |
Last Close | $42.70 | $26.58 |
52 Week Range | $36.82 - $48.12 | $21.84 - $32.88 |
% from 52W High | -11.26% | -19.16% |
All-Time High | $65.67 (May 10, 2021) | $45.87 (Apr 18, 2022) |
% from All-Time High | -34.98% | -42.05% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.14% | 0.07% |
Quarterly Earnings Growth | -0.46% | 213.77% |
Financial Health | ||
Profit Margin (TTM) | 0.04% | 0.61% |
Operating Margin (TTM) | 0.05% | 0.14% |
Return on Equity (TTM) | 0.02% | 0.18% |
Debt to Equity (MRQ) | 54.97 | 45.01 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $24.87 | $14.88 |
Cash per Share (MRQ) | $1.23 | $5.81 |
Operating Cash Flow (TTM) | $161.91M | $242.65M |
Levered Free Cash Flow (TTM) | $129.85M | $255.65M |
Dividends | ||
Last 12-Month Dividend Yield | 5.35% | 3.67% |
Last 12-Month Dividend | $2.25 | $0.83 |
Valuation & Enterprise Metrics Analysis: PotlatchDeltic vs Rayonier
Metric | PCH | RYN |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 80.19 | 10.85 |
Forward P/E | 53.80 | 51.73 |
PEG Ratio | -1.70 | 0.00 |
Price to Sales (TTM) | 3.11 | 3.39 |
Price to Book (MRQ) | 1.71 | 1.81 |
Market Capitalization | ||
Market Capitalization | $3.34B | $4.19B |
Enterprise Value | $4.24B | $4.36B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.02 | 3.52 |
Enterprise to EBITDA | 25.69 | 8.27 |
Risk & Other Metrics | ||
Beta | 1.11 | 1.02 |
Book Value per Share (MRQ) | $24.87 | $14.88 |
Financial Statements Comparison: PotlatchDeltic vs Rayonier
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | PCH | RYN |
---|---|---|
Revenue/Sales | $268.26M | $82.92M |
Cost of Goods Sold | $220.41M | $64.95M |
Gross Profit | $47.86M | $17.97M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $27.51M | $1.17M |
EBITDA | $52.74M | $30.03M |
Pre-Tax Income | $25.46M | $-5.30M |
Income Tax | $-344,000 | $291,000 |
Net Income (Profit) | $25.81M | $-3.09M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | PCH | RYN |
---|---|---|
Cash & Equivalents | $147.48M | $216.24M |
Total Current Assets | $294.85M | $767.39M |
Total Current Liabilities | $206.04M | $282.81M |
Long-Term Debt | $907.71M | $1.06B |
Total Shareholders Equity | $2.01B | $1.98B |
Retained Earnings | $-484.12M | N/A |
Property, Plant & Equipment | N/A | $18.04M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | PCH | RYN |
---|---|---|
Operating Cash Flow | $44.00M | $60.99M |
Capital Expenditures | $-12.11M | N/A |
Free Cash Flow | $29.52M | $43.49M |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | $-3.92M | $-37.57M |
Short Interest & Institutional Ownership Analysis
Metric | PCH | RYN |
---|---|---|
Shares Short | 1.54M | 4.18M |
Short Ratio | 3.23 | 4.42 |
Short % of Float | 0.03% | 0.03% |
Average Daily Volume (10 Day) | 634,590 | 921,870 |
Average Daily Volume (90 Day) | 563,533 | 1,040,337 |
Shares Outstanding | 78.68M | 148.54M |
Float Shares | 70.72M | 138.97M |
% Held by Insiders | 0.02% | 0.01% |
% Held by Institutions | 0.95% | 0.96% |
Dividend Analysis & Yield Comparison: PotlatchDeltic vs Rayonier
Metric | PCH | RYN |
---|---|---|
Last 12-Month Dividend | $2.25 | $0.83 |
Last 12-Month Dividend Yield | 5.35% | 3.67% |
3-Year Avg Annual Dividend | $2.26 | $1.09 |
3-Year Avg Dividend Yield | 1.10% | 0.89% |
3-Year Total Dividends | $6.79 | $3.27 |
Ex-Dividend Date | Sep 15, 2025 | Mar 17, 2025 |